On October 31 and November 1, PAREA participated in the IMBAS Psychedelic Research Conference at Trinity College Dublin, the second edition of Ireland's leading event on psychedelic science. 

In October, PAREA participated in LaPsyConf 2025, the first international conference in Buenos Aires dedicated to rethinking mental health, longevity, and emerging therapeutics. Tadeusz Hawrot, Founder of PAREA, delivered the opening address titled “Global Issues: Mental Health Indicators, Global Regulation, and Economic Impact.”

Spain’s Council of Ministers has formally approved a Royal Decree establishing the country’s first regulatory framework for the medical use of cannabis in standardised preparations. The decision aims to provide an alternative therapeutic option when conventional treatments fail.

The Global Burden of Disease (GBD) 2023 update, published in The Lancet, shows that mental health conditions are rising faster than almost any other group of disorders worldwide. Drawing on data from more than 200 countries, the study remains the most comprehensive analysis of global health loss and life expectancy.